Delivery Order SPE2DB22D2206-SPE2DB24FEK44
Award Date
11/30/23
Potential Completion Date
12/1/23
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,496.95 firm-fixed-price delivery order is for the supply of 4565439755 RAMELTEON 8 MG TABLET UD 50S, a prescription medication. The award has an ultimate completion date of August 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,478.04 fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product, with a completion date of July 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,645.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RAMELTEON 8 MG TABLET UD 50S, with an ultimate completion date of March 4, 2025. The contract type is Firm Fixed Price, and there was no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $7,695.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the provision of RAMELTEON 8 MG TABLET UD 50S, with an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $2,655.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4566964538 - RAMELTEON 8 MG TABLET UD 50S, with an ultimate completion date of January 17, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, SPE2DB20D1100|SPE2DB25FZ68D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of RAMELTEON 8 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $1,061.28 and a completion date of December 20, 2024. This is a delivery order contract, and no set-aside designation was used. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is a delivery order valued at $1,865.82 issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product, with a period of performance through September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts by various defense and civilian...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET 30S. The contract has a ceiling value of $1,543.74 and will run through August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment...
This federal contract award, valued at $1,628.98, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a generic pharmaceutical product, with a period of performance through May 14, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award, identified as SPE2DX15D1022|SPE2DX25FVCUM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $12,401.70, is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. This appears to be a Firm Fixed Price delivery order contract, with a performance period extending to March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...